Drug Profile
Rotavirus vaccine bovine reassortant - Sanofi
Alternative Names: BRV vaccine - Shantha Biotechnics; BRV-TV; Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine - Shantha BiotechnicsLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Shantha Biotechnics
- Class Rotavirus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 02 Mar 2017 No recent reports on development identified - Phase-III for Rotavirus infections (In infants, Prevention) in India (PO)
- 14 Oct 2014 Phase-III clinical trials in Rotavirus infections (In infants, Prevention) in India (PO) (CTRI/2014/08/004893)
- 30 Jun 2013 Shantha Biotechnics completes a phase I/II trial in Rotavirus infections (prevention, in infants) in India (CTRI2012-07-002820)